Free Trial

Wave Life Sciences (WVE) SEC Filings & 10K Form

Wave Life Sciences logo
$11.13 -0.20 (-1.77%)
Closing price 04:00 PM Eastern
Extended Trading
$11.22 +0.09 (+0.81%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Wave Life Sciences SEC Filings

DateFilerForm TypeView
02/06/2025
7:00 PM
Vargeese Chandra (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 PM
Francis Chris (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
4:28 PM
BlackRock, Inc. (Filed by)
Wave Life Sciences (Subject)
Form SCHEDULE 13G/A
01/24/2025
4:30 PM
Vargeese Chandra (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
1:00 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
8:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:09 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
5:05 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
8:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
7:00 PM
Francis Chris (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
10/30/2024
4:13 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
7:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
7:00 PM
Francis Chris (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:13 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
3:19 PM
Francis Chris (Reporting)
Wave Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
7:34 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:15 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:54 PM
GSK plc (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:47 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Wave Life Sciences (Subject)
Form SC 13D/A
10/01/2024
6:35 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
5:09 AM
Wave Life Sciences (Filer)
Form 424B5
09/26/2024
4:18 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
8:40 PM
Moran Kyle (Reporting)
Wave Life Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/24/2024
4:13 PM
Wave Life Sciences (Filer)
Form 424B3
09/24/2024
4:16 PM
Wave Life Sciences (Filer)
Form 424B5
09/24/2024
6:34 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
5:00 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
TAKANASHI KEN (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Wagner Heidi L (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Verdine Gregory L. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
CORRIGAN MARK (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
HENRY CHRISTIAN O (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Tan Aik Na (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Rawcliffe Adrian (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:05 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:29 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Collect $7k per month from Tesla’s SECRET dividend (Ad)

Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…

Click here to discover the new #1 way to invest in Tesla
08/08/2024
6:55 AM
Wave Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:37 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
4:54 PM
Vargeese Chandra (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
6:36 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:26 PM
Wave Life Sciences (Filer)
Form ARS
05/10/2024
6:30 AM
Wave Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:37 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:55 AM
Wave Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
6:39 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:WVE) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners